Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Humanigen Inc (HGEN)

Humanigen Inc (HGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Humanigen Inc 830 Morris Turnpike 4th Floor Short Hills NJ 07078 USA

www.humanigen.com P: 650-243-3100

Description:

Humanigen, Inc. is a biopharmaceutical company. It focuses on advancing medicines for patients with neglected and rare diseases. The Company's product candidate principally consists of benznidazole, lenzilumab and ifabotuzumab. Humanigen Inc., formerly known as KaloBios Pharmaceuticals Inc., is based in Brisbane, United States.

Key Statistics

Overview:

Market Capitalization, $K 24
Enterprise Value, $K -10,136
Shares Outstanding, K 119,080
Annual Sales, $ 2,510 K
Annual Net Income, $ -70,730 K
Last Quarter Sales, $ 220 K
Last Quarter Net Income, $ -4,180 K
EBIT, $ -52,010 K
EBITDA, $ -52,010 K
60-Month Beta -1.04
% of Insider Shareholders 21.70%
% of Institutional Shareholders 4.55%
Float, K 93,240
% Float 78.30%
Short Volume Ratio 0.01

Growth:

1-Year Return -99.88%
3-Year Return -100.00%
5-Year Return -100.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 01/01/24
Earnings Per Share ttm -0.66
EPS Growth vs. Prev Year -82.69%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 09/14/20

HGEN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -2,817.93%
Debt/Equity 0.00
Price/Sales 2.18
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.42
Interest Coverage -23.22
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar